CIPLANSECipla Limited· PharmaceuticalsLowNeutral
Announced Tue, 13 May · 13:52 IST

Cipla Limited has informed the Exchange regarding Appointment of Ms Joshi Apte & Associates as Cost Auditor of the company

Management Changes View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Cipla's Board, on May 13, 2025, approved the appointment of M/s Joshi Apte & Associates as Cost Auditor for FY 2025-26. The Board also recommended appointing M/s BNP & Associates as Secretarial Auditor for a 5-year term from April 1, 2025 to March 31, 2030, subject to shareholder approval at the upcoming AGM. Additionally, M/s B S R & Co. LLP has been recommended as Statutory Auditor for a first 5-year term starting from the conclusion of the 90th AGM (FY 2026-27) through the 95th AGM (FY 2031-32). The current statutory auditor, Walker Chandiok & Co LLP, will complete its second permitted term at the end of the 90th AGM, in line with mandatory auditor rotation rules.

Likely market impact

This is a routine regulatory and compliance matter with no material impact on shareholders. The statutory auditor rotation is mandatory under the Companies Act, and the proposed firms (B S R & Co. LLP, BNP & Associates, Joshi Apte & Associates) are well-established professionals, which supports continued governance quality.